Barbar-Jean Anne Bormann-Kennedy Ph.D.
|Age||Total Calculated Compensation||This person is connected to 106 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Barbar-Jean Anne Bormann-Kennedy, PhD also serves as the Interim Chief Executive Officer of Supportive Therapeutics, LLC. Dr. Bormann served as the Chief Executive Officer and President at Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) since February 05, 2015 until October 16, 2015. Dr. Bormann served as Chief Executive Officer of Harbour Antibodies. Dr. Bormann served as Chief Business Officer of NanoMedical Systems, Inc. She served as Senior ...
1201 Maryland Avenue SWPhone: 202-962-9200
Washington, District Of Columbia 20024
Board Members Memberships*
University of Connecticut Health Center
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.